NO20065939L - Oligonukleotider for cancerdiagnose - Google Patents
Oligonukleotider for cancerdiagnoseInfo
- Publication number
- NO20065939L NO20065939L NO20065939A NO20065939A NO20065939L NO 20065939 L NO20065939 L NO 20065939L NO 20065939 A NO20065939 A NO 20065939A NO 20065939 A NO20065939 A NO 20065939A NO 20065939 L NO20065939 L NO 20065939L
- Authority
- NO
- Norway
- Prior art keywords
- oligonucleotides
- kits
- cancer diagnosis
- proteins involved
- encoding proteins
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Foreliggende oppfinnelse tilveiebringer sett av oligonukleotider som svarer til gener som koder for proteiner involvert i proteinsyntese og/eller -stabilitet eller gener som koder for proteiner involvert i regulering av forsvar og/eller kromatinremodellering for anvendelse i fremstilling av transkriptmønstre spesielt for cancerdiagnose. Foreliggende oppfinnelse omfatter også slike sett og testsett inneholdende slike sett, så vel som relaterte fremgangsmåter som baseres på analyse av markørpolypeptider kodet for ved genene for å utvikle karakteristiske ekspresjonsprofiler.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0412301.4A GB0412301D0 (en) | 2004-06-02 | 2004-06-02 | Product and method |
PCT/GB2005/002180 WO2005118851A1 (en) | 2004-06-02 | 2005-06-02 | Oligonucleotides for cancer diagnosis |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20065939L true NO20065939L (no) | 2007-02-08 |
Family
ID=32696533
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20065939A NO20065939L (no) | 2004-06-02 | 2006-12-20 | Oligonukleotider for cancerdiagnose |
Country Status (17)
Country | Link |
---|---|
US (2) | US8105773B2 (no) |
EP (1) | EP1766056B1 (no) |
JP (1) | JP5060945B2 (no) |
CN (1) | CN101027410A (no) |
AP (1) | AP2006003862A0 (no) |
AT (1) | ATE493511T1 (no) |
AU (1) | AU2005250219B2 (no) |
CA (1) | CA2568889A1 (no) |
DE (1) | DE602005025633D1 (no) |
DK (1) | DK1766056T3 (no) |
ES (1) | ES2358910T3 (no) |
GB (1) | GB0412301D0 (no) |
NO (1) | NO20065939L (no) |
NZ (1) | NZ551797A (no) |
SI (1) | SI1766056T1 (no) |
WO (1) | WO2005118851A1 (no) |
ZA (1) | ZA200610644B (no) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090227692A1 (en) * | 2005-05-26 | 2009-09-10 | The Johns Hopkins University | Biomarkers for breast cancer |
JP2007275027A (ja) * | 2006-04-12 | 2007-10-25 | Fujifilm Corp | 癌関連欠失遺伝子マーカーを用いた癌の診断方法 |
JP5208477B2 (ja) * | 2007-10-12 | 2013-06-12 | 生化学工業株式会社 | 遺伝子サブトラクション用の担体及びその利用 |
JP2013511728A (ja) * | 2009-11-20 | 2013-04-04 | ユニバーシティ オブ ルイスビル リサーチ ファンデーション,インコーポレイテッド | 癌のバイオマーカー |
GB201000688D0 (en) * | 2010-01-15 | 2010-03-03 | Diagenic Asa | Product and method |
CA3120217A1 (en) * | 2011-04-29 | 2012-11-01 | Cancer Prevention And Cure, Ltd. | Methods of identification and diagnosis of lung diseases using classification systems and kits thereof |
AU2012332184B2 (en) * | 2011-11-02 | 2015-11-19 | Cudoquanta Florida, Inc. | Castellated optical fiber cable retention structure |
JP6486826B2 (ja) | 2012-10-01 | 2019-03-20 | ミレニアム ファーマシューティカルズ, インコーポレイテッドMillennium Pharmaceuticals, Inc. | 阻害剤に対する応答を予測するためのバイオマーカーおよび方法、ならびにそれらの使用 |
US20150299806A1 (en) * | 2012-11-20 | 2015-10-22 | University Of Tromsoe | Gene expression profile in diagnostics |
US20160324944A1 (en) | 2013-12-29 | 2016-11-10 | Franco Venanzi | Methods and compositions relating to p62/SQSTM1 for the treatment and prevention of inflammation-associated diseases |
CN111910002B (zh) * | 2014-06-18 | 2024-04-12 | 东丽株式会社 | 食道癌的检测试剂盒或装置以及检测方法 |
FR3029210A1 (fr) | 2014-11-27 | 2016-06-03 | Centre Nat De La Rech Scient (Cnrs) | Methode de pronostic d'hemopathies |
US10140708B2 (en) * | 2016-01-21 | 2018-11-27 | Riverside Research Institute | Method for gestational age estimation and embryonic mutant detection |
GB201611738D0 (en) | 2016-07-05 | 2016-08-17 | Cambridge Entpr Ltd | Biomarkers for inflammatory bowel disease |
CA3065957A1 (en) * | 2017-08-14 | 2019-02-21 | Raytheon Company | Subtraction algorithm for detection of tumors |
CN109529018B (zh) * | 2019-01-10 | 2021-11-30 | 南方医科大学南方医院 | Atxn2l用于制备逆转胃癌奥沙利铂耐药的药物的用途 |
CN109596611A (zh) * | 2019-01-21 | 2019-04-09 | 湖北紫荆生物技术有限公司 | 一种水体钙含量测试剂及水体钙含量测量方法 |
US11475558B2 (en) | 2019-11-13 | 2022-10-18 | Raytheon Company | Organ isolation in scan data |
US11282209B2 (en) | 2020-01-10 | 2022-03-22 | Raytheon Company | System and method for generating contours |
US11893745B2 (en) | 2020-12-09 | 2024-02-06 | Raytheon Company | System and method for generating and displaying contours |
US11562512B2 (en) | 2020-12-09 | 2023-01-24 | Raytheon Company | System and method for generating and displaying contours |
CN113913436B (zh) * | 2021-11-18 | 2023-09-29 | 天津市肿瘤医院(天津医科大学肿瘤医院) | 逆转录转座基因l1-atp8b1及其作为肺鳞癌标志物的用途和治疗肺鳞癌的药物 |
CN115976212B (zh) * | 2022-12-21 | 2024-06-11 | 四川大学华西医院 | 一种用于检测骨肿瘤诊断相关基因的探针库及试剂盒 |
Family Cites Families (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4981783A (en) * | 1986-04-16 | 1991-01-01 | Montefiore Medical Center | Method for detecting pathological conditions |
US5800992A (en) * | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
US5925525A (en) * | 1989-06-07 | 1999-07-20 | Affymetrix, Inc. | Method of identifying nucleotide differences |
US5871928A (en) * | 1989-06-07 | 1999-02-16 | Fodor; Stephen P. A. | Methods for nucleic acid analysis |
US6040138A (en) * | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
JP2802125B2 (ja) | 1989-06-23 | 1998-09-24 | キヤノン株式会社 | 核酸の検出方法 |
US5474796A (en) * | 1991-09-04 | 1995-12-12 | Protogene Laboratories, Inc. | Method and apparatus for conducting an array of chemical reactions on a support surface |
DE69214243T2 (de) | 1991-09-23 | 1997-02-06 | Pfizer | Verfahren für die Detektion von spezifische mRNS und DNS in Zellen |
GB2260811B (en) | 1991-10-23 | 1995-07-05 | Yorkshire Cancer Research Camp | Detection of malignant tumours |
WO1993018143A1 (en) | 1992-03-04 | 1993-09-16 | Synaptic Pharmaceutical Corporation | Dna encoding taurine and gaba transporters and uses thereof |
US6114114A (en) | 1992-07-17 | 2000-09-05 | Incyte Pharmaceuticals, Inc. | Comparative gene transcript analysis |
US5633137A (en) * | 1992-12-01 | 1997-05-27 | The University Of South Florida | Method for measuring specific gene expression: transcriptional activity per gene dose |
US5677125A (en) * | 1994-01-14 | 1997-10-14 | Vanderbilt University | Method of detection and diagnosis of pre-invasive cancer |
WO1997027317A1 (en) | 1996-01-23 | 1997-07-31 | Affymetrix, Inc. | Nucleic acid analysis techniques |
US5830645A (en) * | 1994-12-09 | 1998-11-03 | The Regents Of The University Of California | Comparative fluorescence hybridization to nucleic acid arrays |
US5545531A (en) * | 1995-06-07 | 1996-08-13 | Affymax Technologies N.V. | Methods for making a device for concurrently processing multiple biological chip assays |
US6156502A (en) | 1995-12-21 | 2000-12-05 | Beattie; Kenneth Loren | Arbitrary sequence oligonucleotide fingerprinting |
WO1997029212A1 (en) | 1996-02-08 | 1997-08-14 | Affymetrix, Inc. | Chip-based speciation and phenotypic characterization of microorganisms |
AU4327697A (en) | 1996-08-20 | 1998-03-06 | Motorola, Inc. | Method and apparatus for detecting predetermined molecular structures in a sample |
US6235474B1 (en) | 1996-12-30 | 2001-05-22 | The Johns Hopkins University | Methods and kits for diagnosing and determination of the predisposition for diseases |
US6190857B1 (en) | 1997-03-24 | 2001-02-20 | Urocor, Inc. | Diagnosis of disease state using MRNA profiles in peripheral leukocytes |
NO972006D0 (no) * | 1997-04-30 | 1997-04-30 | Forskningsparken I Aas As | Ny metode for diagnose av sykdommer |
US5994076A (en) * | 1997-05-21 | 1999-11-30 | Clontech Laboratories, Inc. | Methods of assaying differential expression |
WO1999006831A2 (en) | 1997-07-29 | 1999-02-11 | Dorssers Lambert C J | Breast cancer resistance genes, methods for their detection and uses thereof |
US6607879B1 (en) * | 1998-02-09 | 2003-08-19 | Incyte Corporation | Compositions for the detection of blood cell and immunological response gene expression |
US6174680B1 (en) * | 1998-12-30 | 2001-01-16 | Dana-Farber Cancer Institute, Inc. | Method for identifying mismatch repair glycosylase reactive sites, compounds and uses thereof |
ATE347102T1 (de) | 1998-02-25 | 2006-12-15 | Us Health | Zellulare anordnungen für schnelle molekulare profilidentifizierung |
US6004755A (en) * | 1998-04-07 | 1999-12-21 | Incyte Pharmaceuticals, Inc. | Quantitative microarray hybridizaton assays |
JP2002524091A (ja) | 1998-08-21 | 2002-08-06 | ナックスコー・インコーポレイテッド | 架橋可能な固定化核酸を用いるアッセイ |
US20080261292A1 (en) * | 1998-09-22 | 2008-10-23 | Oncomedx, Inc. | Method Enabling the Use of Extracellular Ribonucleic Acid (RNA) Extracted from Plasma or Serum to Detect, Monitor or Evaluate Cancer or Premalignant Conditions |
US6593084B2 (en) | 1998-10-13 | 2003-07-15 | Robert E. Bird | Carcinogen assay |
EP1121471A1 (en) | 1998-10-13 | 2001-08-08 | Clontech Laboratories, Inc. | Nucleic acid arrays |
WO2000024940A1 (en) | 1998-10-28 | 2000-05-04 | Vysis, Inc. | Cellular arrays and methods of detecting and using genetic disorder markers |
WO2000026412A1 (en) | 1998-11-02 | 2000-05-11 | Kenneth Loren Beattie | Nucleic acid analysis using sequence-targeted tandem hybridization |
US20040241728A1 (en) * | 1999-01-06 | 2004-12-02 | Chondrogene Limited | Method for the detection of lung disease related gene transcripts in blood |
US7473528B2 (en) * | 1999-01-06 | 2009-01-06 | Genenews Inc. | Method for the detection of Chagas disease related gene transcripts in blood |
US20040241727A1 (en) * | 1999-01-06 | 2004-12-02 | Chondrogene Limited | Method for the detection of schizophrenia related gene transcripts in blood |
CA2359816C (en) * | 1999-01-06 | 2010-08-03 | Genenews Inc. | Method for the detection of gene transcripts in blood and uses thereof |
US20040248170A1 (en) * | 1999-01-06 | 2004-12-09 | Chondrogene Limited | Method for the detection of hyperlipidemia related gene transcripts in blood |
US20040265868A1 (en) * | 1999-01-06 | 2004-12-30 | Chondrogene Limited | Method for the detection of depression related gene transcripts in blood |
US20040248169A1 (en) * | 1999-01-06 | 2004-12-09 | Chondrogene Limited | Method for the detection of obesity related gene transcripts in blood |
US20050123938A1 (en) | 1999-01-06 | 2005-06-09 | Chondrogene Limited | Method for the detection of osteoarthritis related gene transcripts in blood |
US20040265869A1 (en) * | 1999-01-06 | 2004-12-30 | Chondrogene Limited | Method for the detection of type II diabetes related gene transcripts in blood |
US20050042630A1 (en) * | 1999-01-06 | 2005-02-24 | Chondrogene Limited | Method for the detection of asthma related gene transcripts in blood |
US20040241726A1 (en) * | 1999-01-06 | 2004-12-02 | Chondrogene Limited | Method for the detection of allergies related gene transcripts in blood |
US20050003394A1 (en) * | 1999-01-06 | 2005-01-06 | Chondrogene Limited | Method for the detection of rheumatoid arthritis related gene transcripts in blood |
DE19937187A1 (de) * | 1999-08-06 | 2001-03-01 | Qiagen Gmbh | Automatisierte Proteinreinigung im Multiwellformat durch Vakuumfiltration |
WO2002008262A2 (en) * | 2000-07-26 | 2002-01-31 | Stanford University | Bstp-5 proteins and related reagents and methods of use thereof |
US7108969B1 (en) * | 2000-09-08 | 2006-09-19 | Affymetrix, Inc. | Methods for detecting and diagnosing oral cancer |
US6955876B2 (en) * | 2000-11-01 | 2005-10-18 | Kane Michael D | Compositions and systems for identifying and comparing expressed genes (mRNAs) in eukaryotic organisms |
WO2002059367A2 (en) | 2000-11-30 | 2002-08-01 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Diagnostic microarray for inflammatory bowel disease, crohn's disease and ulcerative colitis |
AU2002246970B2 (en) * | 2001-01-12 | 2007-06-14 | Yale University | Detection of survivin in the biological fluids of cancer patients |
US20020132274A1 (en) * | 2001-01-17 | 2002-09-19 | Nevalainen Marja T. | Diagnostic and monitorings methods for cancer |
WO2002059271A2 (en) | 2001-01-25 | 2002-08-01 | Gene Logic, Inc. | Gene expression profiles in breast tissue |
BR0207657A (pt) | 2001-02-28 | 2004-10-26 | Chondrogene Inc | Uma ou mais sequências de polinucleotìdeos isoladas, vetor, célula hospedeira, composição, disposição, métodos para diagnosticar as osteoartrites branda, moderada, acentuada e grave em um paciente, para identificar um agente que aumenta ou diminui a expressão de uma sequência de polinucleotìdeos, para preparar uma coleção de cdna de condrócito, e para fabricar uma disposição, e conjunto |
WO2002088750A2 (en) * | 2001-05-02 | 2002-11-07 | Oxford Glycosciences (Uk) Ltd | Proteins, genes and their use for diagnosis and treatment of breast cancer |
US20020169560A1 (en) * | 2001-05-12 | 2002-11-14 | X-Mine | Analysis mechanism for genetic data |
US7335467B2 (en) * | 2001-05-15 | 2008-02-26 | Ludwig Institute For Cancer Research | Breast cancer antigens |
US20030036077A1 (en) * | 2001-05-31 | 2003-02-20 | Chronix Biomedical | Methods for generating an mRNA expression profile from an ecellular mRNA containing blood sample and using the same to identify functional state markers |
US7297480B2 (en) * | 2001-06-28 | 2007-11-20 | Dermtech International | Method for detection of melanoma |
US20030099973A1 (en) * | 2001-07-18 | 2003-05-29 | University Of Louisville Research Foundation, Inc. | E-GeneChip online web service for data mining bioinformatics |
US7229774B2 (en) * | 2001-08-02 | 2007-06-12 | Regents Of The University Of Michigan | Expression profile of prostate cancer |
US7622260B2 (en) * | 2001-09-05 | 2009-11-24 | The Brigham And Women's Hospital, Inc. | Diagnostic and prognostic tests |
US7371736B2 (en) * | 2001-11-07 | 2008-05-13 | The Board Of Trustees Of The University Of Arkansas | Gene expression profiling based identification of DKK1 as a potential therapeutic targets for controlling bone loss |
AU2002359357A1 (en) * | 2001-11-07 | 2003-07-09 | The Board Of Trustees Of The University Of Arkansas | Diagnosis prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling |
US20030232350A1 (en) * | 2001-11-13 | 2003-12-18 | Eos Biotechnology, Inc. | Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer |
WO2003041562A2 (en) * | 2001-11-14 | 2003-05-22 | Whitehead Institute For Biomedical Research | Molecular cancer diagnosis using tumor gene expression signature |
US20040241653A1 (en) * | 2001-12-31 | 2004-12-02 | Elena Feinstein | Methods for identifying marker genes for cancer |
US20030195431A1 (en) * | 2002-04-10 | 2003-10-16 | Sukhatme Vikas P. | Observation of effects of body fluids on indicator cells for disease diagnosis |
AU2003239544A1 (en) * | 2002-05-24 | 2003-12-12 | Tularik Inc. | Amplification and overexpression of oncogenes |
CN100478689C (zh) * | 2002-08-30 | 2009-04-15 | 肿瘤疗法科学股份有限公司 | 多肽及其用途 |
US7452667B2 (en) | 2002-09-12 | 2008-11-18 | Genenews, Inc. | Diagnosis of mild osteoarthritis by determination of TNFAIP6 and TGFBI RNA levels |
US20060024692A1 (en) * | 2002-09-30 | 2006-02-02 | Oncotherapy Science, Inc. | Method for diagnosing non-small cell lung cancers |
GB0227238D0 (en) * | 2002-11-21 | 2002-12-31 | Diagenic As | Product and method |
US7910550B2 (en) * | 2004-04-16 | 2011-03-22 | Stc.Unm | Human kunitz-type inhibitor with enhanced antifibrinolytic activity |
US20090118132A1 (en) * | 2004-11-04 | 2009-05-07 | Roche Molecular Systems, Inc. | Classification of Acute Myeloid Leukemia |
US20070178503A1 (en) * | 2005-12-19 | 2007-08-02 | Feng Jiang | In-situ genomic DNA chip for detection of cancer |
-
2004
- 2004-06-02 GB GBGB0412301.4A patent/GB0412301D0/en not_active Ceased
-
2005
- 2005-06-02 SI SI200531251T patent/SI1766056T1/sl unknown
- 2005-06-02 DK DK05747218.5T patent/DK1766056T3/da active
- 2005-06-02 WO PCT/GB2005/002180 patent/WO2005118851A1/en active Application Filing
- 2005-06-02 EP EP05747218A patent/EP1766056B1/en active Active
- 2005-06-02 NZ NZ551797A patent/NZ551797A/en not_active IP Right Cessation
- 2005-06-02 AU AU2005250219A patent/AU2005250219B2/en not_active Ceased
- 2005-06-02 AP AP2006003862A patent/AP2006003862A0/xx unknown
- 2005-06-02 CN CN200580026265.8A patent/CN101027410A/zh active Pending
- 2005-06-02 AT AT05747218T patent/ATE493511T1/de not_active IP Right Cessation
- 2005-06-02 ES ES05747218T patent/ES2358910T3/es active Active
- 2005-06-02 ZA ZA200610644A patent/ZA200610644B/en unknown
- 2005-06-02 JP JP2007514130A patent/JP5060945B2/ja not_active Expired - Fee Related
- 2005-06-02 US US11/628,300 patent/US8105773B2/en not_active Expired - Fee Related
- 2005-06-02 CA CA002568889A patent/CA2568889A1/en not_active Abandoned
- 2005-06-02 DE DE602005025633T patent/DE602005025633D1/de active Active
-
2006
- 2006-12-20 NO NO20065939A patent/NO20065939L/no not_active Application Discontinuation
-
2012
- 2012-01-05 US US13/344,088 patent/US20120295800A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
SI1766056T1 (sl) | 2011-05-31 |
NZ551797A (en) | 2010-03-26 |
AU2005250219B2 (en) | 2011-01-20 |
DE602005025633D1 (no) | 2011-02-10 |
ATE493511T1 (de) | 2011-01-15 |
AP2006003862A0 (en) | 2006-12-31 |
CN101027410A (zh) | 2007-08-29 |
US20120295800A1 (en) | 2012-11-22 |
WO2005118851A1 (en) | 2005-12-15 |
EP1766056A1 (en) | 2007-03-28 |
JP5060945B2 (ja) | 2012-10-31 |
JP2008501332A (ja) | 2008-01-24 |
US8105773B2 (en) | 2012-01-31 |
ZA200610644B (en) | 2008-07-30 |
AU2005250219A1 (en) | 2005-12-15 |
CA2568889A1 (en) | 2005-12-15 |
EP1766056B1 (en) | 2010-12-29 |
ES2358910T3 (es) | 2011-05-16 |
US20080026385A1 (en) | 2008-01-31 |
DK1766056T3 (da) | 2011-03-14 |
GB0412301D0 (en) | 2004-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20065939L (no) | Oligonukleotider for cancerdiagnose | |
NO20082559L (no) | Humane monoklonale antistoffer mot protein tyrosin kinase 7 (PTK7) og fremgangsmater for anvendelse av anti-PTK7 antistoffer | |
CY1118979T1 (el) | Αντισωματα που κατευθυνονται εναντι her-3 και χρησεις αυτων | |
NO20060235L (no) | Sammensetninger og fremgangsmater for a oke benmineralisering | |
PE20081392A1 (es) | Moleculas de enlace de lingo | |
WO2022026475A3 (en) | Multimeric coronavirus binding molecules and uses thereof | |
BRPI0922350A2 (pt) | anticorpo humano, mólecula biespecífica,vetor de expressão, célula hospedeira eucariótica ou procariótoca recombinante, composição farmacêutica, uso do anticorpo ou da molécula biespecífica, métodos para inibir o desenvolvimento e/ou proliferação de uma célula tumoral que expressa o fator de tecido, para produzir um anticorpo, e para detectar a presença de fator de tecido em uma amostra, composição de diagnóstico, e, kit para detectar a presença de fator de tecido em uma amostra. | |
NO20092285L (no) | Humane, monoklonale antistoffer til BTLA og fremgangsmater for anvendelse | |
EA201990619A1 (ru) | Fgf21 мутанты и их применение | |
WO2005107491A3 (en) | Multi-lectin affinity chromatography and uses thereof | |
DK1641818T3 (da) | Polypeptider der har bindingsaffinitet for HER2 | |
WO2005005462A3 (en) | Blys antagonists and uses thereof | |
EA201690946A1 (ru) | Мутанты fgf21 и их применение | |
DE602006017365D1 (de) | Zusammensetzungen für die identifizierung von adenoviren | |
EA200901313A1 (ru) | Ингибиторы тирозинкиназы брутона | |
NO20074389L (no) | Bestemmelse av respondere til kjemoterapi | |
WO2009073505A3 (en) | Methods for processing tandem mass spectral data for protein sequence analysis | |
BRPI0413728B8 (pt) | muteína da lipocalina da lágrima humana, métodos para geração e para produção de muteína, composição farmacêutica e uso de muteína | |
ATE541283T1 (de) | Verfahren zum mischen von farben in einem display | |
DK1608399T3 (da) | Kompleks af sclerostin og noggin eller chordin og stoffer, som modulerer dannelsen af komplekset | |
ATE504602T1 (de) | Für humane matriptase spezifische bindungsproteine | |
EA201400526A1 (ru) | Смесь связанного триптофана в составе пептидов и связанного триптофана в составе полипептидов | |
JP2009537798A5 (no) | ||
WO2007067814A3 (en) | Targeting gli proteins in human cancer by small molecules | |
DK2021794T3 (da) | Anvendelse af protein S100A 12 som en markør for colorektal cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |